Share Your Pharmacy Pet Peeves

Published Online: Monday, January 1, 2007

It is no secret that pet peeves come with any profession. Pharmacy Times wants to know what ticks you off. In each issue of our ePharmacy Times newsletter, we will continue our ongoing list of pharmacists' complaints. Perhaps you'll identify with one and nod your head in agreement because you're not alone. Please e-mail your complaints along with your name to Eileen Koutnik-Fotopoulos at Here are some pet peeves pharmacists have submitted:

16. Dealing with people who are too lazy to find out the correct day's supply on "as directed" blood glucose test strip prescriptions.—Steve Bristow

17. Handling patients who call the pharmacy super hot under the collar, ask you a question, and then when you finally figure out what they are asking, they answer their own question.—Mindy J. Davis

18. Answering the phone when a patient tells you, "I just talked to my doctor's office about getting a prescription for a medication that my doctor and I had previously talked about. The doctor's office told me to call my pharmacy and have them fax a request to their office."—Felicia Huckaba

19. Filling a prescription for a patient who drops off a new prescription during a very busy period and is astonished when you tell them they have to wait. They then exclaim, "All you have to do is slap a label on it."—Julia Rivera

20. Having it always be our fault when a patient's insurance company adjudicates with a higher copay than the patient paid the last time. Never mind that the last time was months ago or that their formulary has changed since the last time.—Charlee Mong

Latest Articles
This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings and more.
Chronic kidney disease incidence has grown faster than many of its common comorbidities such as diabetes and hypertension, and medications may be an underappreciated driver of this growth.
President Barack Obama’s fiscal year 2017 budget proposal calls for an additional $1.1 billion to combat the nation’s spiraling opioid epidemic.
Baxter International is voluntarily recalling intravenous solution due to leaking containers and the potential for particulate matter.
Latest Issues